<?xml version="1.0" encoding="UTF-8"?>



<records>

  <record>
    <language>eng</language>
          <publisher>Oriental Scientific Publishing Company</publisher>
        <journalTitle>Biomedical and Pharmacology Journal</journalTitle>
          <issn>0974-6242</issn>
            <publicationDate>2025-03-31</publicationDate>
    
        <volume>18</volume>
        <issue>1</issue>

 
    <startPage>739</startPage>
    <endPage>748</endPage>

	 
      <doi>10.13005/bpj/3124</doi>
        <publisherRecordId>65097</publisherRecordId>
    <documentType>article</documentType>
    <title language="eng">Effectiveness and Adverse Drug Reaction Mechanisms Associated with Valproic Acid Use: A Cross-Sectional Prospective Study in Indonesia</title>

    <authors>
	 


      <author>
       <name>Vitarani Dwi Ananda Ningrum</name>

 
		
	<affiliationId>1</affiliationId>
      </author>
    

	 


      <author>
       <name>Irine Dyah Widyastuti</name>


		
	<affiliationId>1</affiliationId>

      </author>
    

	 


      <author>
       <name>Rizaldy Taslim Pinzon</name>

		
	<affiliationId>2</affiliationId>
      </author>
    

	 


      <author>
       <name>Rochmy Istikharah</name>

		
	<affiliationId>1</affiliationId>
      </author>
    


	 


      <author>
       <name>Nashrul Hanif Al-Hakim</name>

		
	<affiliationId>1</affiliationId>
      </author>
    


	 


      <author>
       <name>Naning Ni’mawati</name>

		
	<affiliationId>1</affiliationId>
      </author>
    
    </authors>
    
	    <affiliationsList>
	    
		
		<affiliationName affiliationId="1">Department of Pharmacy, Universitas Islam Indonesia, Yogyakarta, Indonesia</affiliationName>
    

		
		<affiliationName affiliationId="2">Faculty of Medicine, Universitas Kristen Duta Wacana, Yogyakarta, Indonesia </affiliationName>
    
		
		
		
		
	  </affiliationsList>






    <abstract language="eng">Valproic acid (VPA) is a broad-spectrum antiepileptic drug that can also be used to treat bipolar and other neurological disorders. Meanwhile, interindividual variability is known to significantly affect the clinical response to VPA use. This study aims to analyze the factors that affect the clinical response to VPA and prevalence of VPA adverse drug reactions (ADRs). An observational study with a prospective cross-sectional design was conducted by involving 87 outpatients from two private hospitals known for their excellence in neurology. The data on patients’ demographic characteristics, the treatment received, clinical response to VPA, and adverse drug reactions (ADRs) were obtained from the medical records and patient interview. The clinical response to VPA was also confirmed by the patients’ attending doctor, while the ADRs referred to the laboratory data on liver function and data from the medical records. A total of 84 patients (96.6%) receiving VPA showed the expected clinical response. There were no factors correlating with the effectiveness of VPA use (p&gt;0.05). However, more than half of the patients experienced ADRs due to VPA use, including weight gain, hair loss, and hepatotoxicity. Although most of the patients have had their disorders controlled by VPA, an individualized approach is required to avoid the prevalence of ADRs, especially for patients with high-risk factors.</abstract>

    <fullTextUrl format="html">https://biomedpharmajournal.org/vol18no1/effectiveness-and-adverse-drug-reaction-mechanisms-associated-with-valproic-acid-use-a-cross-sectional-prospective-study-in-indonesia/</fullTextUrl>

<keywords language="eng">

      
        <keyword>Adverse drug reaction</keyword>
      

      
        <keyword> Cross-Sectional</keyword>
      

      
        <keyword> Effectiveness</keyword>
      

      
        <keyword> Indonesia</keyword>
      

      
        <keyword> Valproic acid</keyword>
      
</keywords>
  </record>
</records>